Cargando…
Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease
BACKGROUND AND PURPOSE: There is some controversy regarding heterozygous mutations of the gene encoding parkin (PARK2) as risk factors for Parkinson's disease (PD), and all previous studies have been performed in non-Asian populations. Dosage mutation of PARK2, rather than a point mutation or s...
Autores principales: | Chu, Min Kyung, Kim, Won Chan, Choi, Jung Mi, Hong, Jeong-Hoon, Kang, Suk Yun, Ma, Hyeo-Il, Kim, Yun Joong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101102/ https://www.ncbi.nlm.nih.gov/pubmed/25045378 http://dx.doi.org/10.3988/jcn.2014.10.3.244 |
Ejemplares similares
-
Erratum: Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease
por: Chu, Min Kyung, et al.
Publicado: (2015) -
Drug-induced Parkinsonism: A strong predictor of idiopathic Parkinson’s disease
por: Jeong, Sohyun, et al.
Publicado: (2021) -
Long-term prognosis of symptomatic isolated middle cerebral artery disease in Korean stroke patients
por: Oh, Mi Sun, et al.
Publicado: (2011) -
Utility of the Midbrain Tegmentum Diameter in the Differential Diagnosis of Progressive Supranuclear Palsy from Idiopathic Parkinson's Disease
por: Kim, Yool-Hee, et al.
Publicado: (2015) -
Huntington’s Disease Presenting as Adult-Onset Parkinsonism
por: Kwak, In Hee, et al.
Publicado: (2022)